Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DX25F6ACU
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $74,174
Award facts
- Contract value 100% obligated
- $74,173.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $74,173.95 on August 11, 2025, for the supply of Entyvio 300 mg vials. This firm fixed-price delivery order, with an ultimate completion date of September 2, 2025, is funded through the Medical Supply Chain, a defense-focused federal agency. The award carries no set-aside designation, indicating that DMS Pharmaceutical Group competed on an open basis despite its small business status. The place of performance is Park Ridge, Illinois, where the vendor maintains its primary operations.
This delivery order is issued under DMS Pharmaceutical Group's substantial single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC framework enables the issuance of firm fixed-price delivery orders for pharmaceutical products supporting military health facilities worldwide. Entyvio, a biologic medication commonly used in gastroenterology, represents one component of the vendor's extensive portfolio of branded and generic prescription drugs, biologics, and medical consumables supplied to Department of Defense healthcare sites. DMS Pharmaceutical Group's consistent success in securing pharmaceutical supply contracts positions it as a critical supplier within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DX25F6ACU?
SPE2DX25F6ACU was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 11, 2025.
How much is contract SPE2DX25F6ACU worth?
The government has obligated $74,174 on SPE2DX25F6ACU.
Is contract SPE2DX25F6ACU an order under another contract?
Yes. SPE2DX25F6ACU is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6ACU competed?
The extent of competition for SPE2DX25F6ACU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award